Development of a risk stratification tool for rapidly progressive diabetic retinopathy in type 2 diabetes - Top-Institutions - MDSpire

Development of a risk stratification tool for rapidly progressive diabetic retinopathy in type 2 diabetes

  • By

  • Aiping Gu

  • Zhichao Yan

  • Yi Wu

  • Yanying Li

  • Renlong Liang

  • Xiaodi Tang

  • Mengke Li

  • June 19, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, Florida

    Key Differentiators

    • Ophthalmology

  • #2

    Wilmer Eye Institute
    Wilmer Eye Institute

    Baltimore, Maryland

    Key Differentiators

    • Ophthalmology

Original Source(s)

Development of a risk stratification tool for rapidly progressive diabetic retinopathy in type 2 diabetes

  • by Aiping Gu, Zhichao Yan, Yi Wu, Yanying Li, Renlong Liang, Xiaodi Tang, Mengke Li

  • June 19, 2026

Related Content

AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Update on Diabetic Disease

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.